Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevation Oncology, Inc. - Common stock (NQ:ELEV)

0.2400 -0.0100 (-4.00%)
Streaming Delayed Price Updated: 2:53 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Elevation Oncology, Inc. - Common stock

< Previous 1 2 3 4 5 Next >
Tesla To $410? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Here are the top movers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Top movers in Thursday's session
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Recap: Elevation Oncology Q4 Earnings
Via Benzinga
How Is The Market Feeling About Elevation Oncology?
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Which stocks are gapping on Thursday?
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase
Via Benzinga
Exposures Fossil Fuels
Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70%
Elevation Oncology ends EO-3021 development after Phase 1 results, shifts focus to EO-1022, and plans a major workforce reduction to extend funding. 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
Elevation Oncology's ADCs target CLDN18.2 and HER3, with EO-3021 showing promising Phase 1 results and a $6.6 billion TAM in gastric and pancreatic cancers. 
Via Benzinga
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday?
Elevation Oncology shares dropped after initial data from the Phase 1 trial of EO-3021 showed a 42.8% objective response rate in patients with advanced solid tumors expressing Claudin 18.2. No Grade 4... 
Via Benzinga
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Dow Jumps Over 300 Points; US Trade Gap Narrows In June
Via Benzinga
Topics Stocks
Exposures US Equities
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins. 
Via Benzinga
7 Top Stocks to Buy for Under $10: May 2024
By diversifying your portfolio with top stocks for under $10, you can profit from companies that are just starting their growth stories. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024
ELEV stock results show that Elevation Oncology missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
7 Top Stocks Under $7
Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now. 
Via InvestorPlace
5 Healthcare Stocks to Buy for 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023
ELEV stock results show that Elevation Oncology beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Trim the Fat: 3 Overbought Stocks Poised for a Pullback
While these companies have seen a stratospheric rise in their market value, they’re now candidates for overbought stocks to sell. 
Via InvestorPlace
3 Stock Winners That Are Up 400% or More in 2024
Explore stocks winners of 2024, including MicroCloud, Beamr Imaging, and Elevation Oncology, each seeing 400% gains in a GenAI-led rally. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.